Showing results (201-210 of 210) with videos related to
Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
Clinical Nephrology|February 13, 1999
Does early anemia correction prevent complications of chronic renal failure?T B Drüeke, K U Eckardt, U Frei, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 22, 2001
Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulinL Schaefer, I Raslik, H J Grone, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 21, 2006
A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) TrialH Reinecke, M Fobker, J Wellmann, et al.International Journal of Clinical Practice|January 23, 1999
Improved tolerability of felodipine compared with amlodipine in elderly hypertensives: a randomised, double-blind study in 535 patients, focusing on vasodilatory adverse events. The International Study GroupR M Schaefer, P M Aldons, E D Burgess, et al.Clinical Nephrology|September 17, 2008
Efficacy of cinacalcet administered with the first meal after dialysis: the SENSOR StudyR M Schaefer, J Bover, F Dellanna, et al.Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 20, 2010
Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltrationR Merline, S Lazaroski, A Babelova, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Human chronic kidney allograft rejection is accompanied by increased intraglomerular cathepsin B and L activityL Paczek, J Pazik, M Teschner, et al.Oncogene|May 8, 2012
Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatmentM Weiler, P-N Pfenning, A-L Thiepold, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2011
Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patientsU Brunnberg, M Mohr, R Noppeney, et al.Vox Sanguinis|August 26, 2018
Vox Sanguinis International Forum on the use of prehospital blood products and pharmaceuticals in the treatment of patients with traumatic haemorrhageM H Yazer, P C Spinella, S Allard, et al.Pageof 21